NIH-funded research R01 grant

Understanding how certain proteins affect liver damage from acetaminophen overdose

Official title: Novel proteolytic mechanisms driving pathologic hepatic congestion in drug-induced hepatotoxicity

Funded at Michigan State University · NIH-11032017 · Data updated 2026-11-12

This study is looking at how a protein called macrophage elastase might help protect the liver from damage caused by too much acetaminophen, with the goal of finding better treatments for people who have taken too much of this common pain reliever.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMichigan State University
NIH-funded
Lab location1 site (East Lansing, United States)
Project startMay 11, 2023
Project endFebruary 28, 2027
Funding year2025
Award (this year)$444,931
NIH project number5R01DK135649-03
Project IDNIH-11032017 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced acetaminophen overdose or are at risk of acute liver injury due to acetaminophen use.

Less likely to help

Patients who have liver damage from causes other than acetaminophen overdose may not benefit from this research.

What this research studies

This research investigates the mechanisms behind liver injury caused by acetaminophen overdose, which is a leading cause of acute liver failure. The team is exploring how a specific protein, macrophage elastase (MMP-12), can help prevent the worsening of liver damage by regulating the production of another protein involved in inflammation. By using advanced experimental techniques and data from patients, the researchers aim to identify new treatment strategies that could improve outcomes for those affected by acetaminophen toxicity.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from acetaminophen overdose, potentially reducing hospital stays and improving recovery rates.

How similar studies have gone: Previous research has shown promising results in understanding liver injury mechanisms, but this specific approach focusing on MMP-12 is relatively novel.

Where this research is happening

  • Michigan State University
    East Lansing, United States
    Active

Researchers

  • Principal investigator: Luyendyk, James P — Michigan State University
  • Study coordinator: Luyendyk, James P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.